(PDF) Downregulation of miR-544 in Tissue, but Not in

Downregulation of miR-544 in Tissue, but Not in Serum, Is a Novel Biomarker of Malignant Transformation in Glioma

Oncology Letters - Greece

doi 10.3892/ol.2012.918

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

January 1, 2012

Authors

Publisher

Spandidos Publications

Related search

Telomerase Activity: A Biomarker of Cell Proliferation, Not Malignant Transformation

Journal of Urology

English

Circulating miR-150 in CSF Is a Novel Candidate Biomarker for Multiple Sclerosis

Neurology: Neuroimmunology and NeuroInflammation

English

Epigenetic Silencing of KAZALD1 Confers a Better Prognosis and Is Associated With Malignant Transformation/Progression in Glioma

Oncology Reports

Cancer Research

English

Serum miR-26a as a Diagnostic and Prognostic Biomarker in Cholangiocarcinoma

English

Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Clinical Laboratory Analysis

Medical Laboratory Technology

Clinical Biochemistry

Occupational Health

English

Local but Not Systemic Capillary Lactate Is a Reperfusion Biomarker in Experimental Acute Limb Ischaemia

European Journal of Vascular and Endovascular Surgery

Cardiovascular Medicine

English

Circulating FABP4 Is a Prognostic Biomarker in Patients With Acute Coronary Syndrome but Not in Asymptomatic IndividualsSignificance

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

English

miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients With Gastric Cancer

Gastroenterology Research and Practice

Gastroenterology

English

Soluble Neural-Cadherin as a Novel Biomarker for Malignant Bone and Soft Tissue Tumors

Cancer Research

English